+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Complementary & Alternative Medicine For Anti Aging & Longevity Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • July 2026
  • Region: Global
  • 360iResearch™
  • ID: 5665938
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Complementary & Alternative Medicine For Anti Aging & Longevity Market is projected to reach USD 117.03 Billion in 2026. It is expected to continue growing at a CAGR of 17.67%, reaching USD 311.51 Billion by 2032.

Complementary and alternative medicine for anti-aging and longevity is moving from the wellness periphery to a more structured, evidence-seeking ecosystem spanning traditional medicine, herbal formulations, nutraceuticals, mind-body therapies, acupuncture, Ayurveda, traditional Chinese medicine, naturopathy, functional nutrition, movement therapies, and digital wellness coaching. Demand is being shaped by global population aging, the rising prevalence of chronic noncommunicable diseases, consumer interest in preventive health, and growing attention to healthspan rather than lifespan alone. Public health authorities consistently identify physical activity, balanced nutrition, smoking cessation, sleep quality, stress reduction, and social connection as core determinants of healthy aging, creating a strong behavioral foundation for longevity-oriented complementary approaches. At the same time, the sector faces heightened scrutiny around clinical evidence, product quality, practitioner credentials, safety monitoring, and claims substantiation. Successful stakeholders are therefore positioning anti-aging and longevity offerings around integrative care, transparent sourcing, measurable outcomes, and responsible communication that avoids unverified disease-treatment or age-reversal promises.

Transformative Shifts in the Anti-Aging and Longevity CAM Landscape

The landscape is being transformed by the convergence of preventive healthcare, personalized wellness, digital therapeutics, and traditional healing systems. Consumers increasingly seek interventions that support energy, mobility, immune resilience, cognitive performance, metabolic health, sleep, and stress adaptation, while healthcare professionals are more willing to discuss complementary modalities when safety, evidence, and coordination with conventional care are clear. Regulatory bodies in many jurisdictions are tightening oversight of dietary supplements, herbal medicines, medical claims, product labeling, and adverse event reporting, pushing the sector toward higher-quality manufacturing and more disciplined marketing. Scientific interest is also shifting from generic anti-aging narratives to mechanisms linked with inflammation, oxidative stress, metabolic dysfunction, gut microbiome balance, musculoskeletal preservation, neurocognitive health, and hormonal changes associated with aging. This transition favors integrated protocols that combine nutrition, movement, mindfulness, botanicals, and practitioner-guided care with objective biomarkers and longitudinal tracking.

Cumulative Impact of Artificial Intelligence on Longevity-Focused CAM

Artificial intelligence is becoming a cumulative force across complementary and alternative medicine for anti-aging and longevity by improving personalization, evidence synthesis, consumer engagement, and operational quality. AI-enabled platforms can analyze lifestyle data, sleep patterns, activity metrics, nutrition logs, wearable device outputs, and patient-reported outcomes to help tailor wellness plans and identify adherence barriers. In research and product development, machine learning supports literature mapping, bioactive compound screening, safety signal detection, and formulation optimization, particularly for complex botanical and nutraceutical ingredients. In clinical and wellness settings, AI can support triage, coaching, remote monitoring, and outcome tracking, provided that tools are validated, explainable, privacy-protective, and supervised by qualified professionals. The most credible uses of AI in longevity-focused CAM will be those that strengthen evidence-based decision-making rather than amplify unverified claims, especially for older adults, individuals taking prescription medicines, and consumers with chronic conditions who may face herb-drug interaction risks.

Key Regional Insights Across Asia-Pacific, Europe, North America, Latin America, Africa, and the Middle East

Asia-Pacific is a major center for complementary and alternative medicine because traditional Chinese medicine, Ayurveda, Kampo, Korean traditional medicine, yoga, meditation, herbal therapies, and food-as-medicine practices are deeply embedded in cultural and healthcare systems. Population aging in China, Japan, South Korea, Australia, and several Southeast Asian economies is reinforcing interest in mobility, cognition, metabolic health, and healthy aging programs, while India’s Ayurveda and yoga ecosystems are increasingly linked with preventive health and wellness tourism. North America shows strong adoption of dietary supplements, functional nutrition, chiropractic care, acupuncture, mindfulness, and integrative medicine, with consumer demand supported by high awareness of preventive wellness and digital health tools; however, enforcement attention around claims, supplement quality, and practitioner scope remains a defining factor. Latin America has a rich tradition of botanical medicine, community-based healing, and natural product use, with Brazil and Mexico standing out for biodiversity-linked wellness practices and growing consumer interest in preventive aging solutions. Europe demonstrates structured integration in selected areas such as herbal medicinal products, homeopathy, anthroposophic medicine, acupuncture, and naturopathy, while the European regulatory environment emphasizes safety, quality, labeling, and substantiated health claims. The Middle East is experiencing rising interest in wellness, longevity clinics, nutrition programs, traditional remedies, and preventive care, especially in high-income Gulf economies managing lifestyle-related chronic disease burdens. Africa has extensive use of traditional medicine and medicinal plants, with public health relevance in primary care access and community health; the region’s opportunity depends on strengthening quality control, documentation, conservation of botanical resources, practitioner training, and safe integration with conventional healthcare.

Key Group Insights Across NATO, G7, BRICS, European Union, ASEAN, and GCC

ASEAN markets combine deep-rooted herbal, massage, meditation, and traditional healing practices with expanding wellness tourism and preventive health awareness, particularly in countries where aging populations and urban lifestyles are reshaping consumer priorities. The GCC is increasingly oriented toward premium wellness, preventive medicine, longevity clinics, nutrition optimization, and digitally enabled health management, supported by national health transformation agendas that emphasize chronic disease prevention and healthier lifestyles. The European Union provides one of the most structured environments for complementary and alternative medicine products, with rigorous rules covering food supplements, traditional herbal medicinal products, health claims, safety monitoring, and consumer protection, making compliance and evidence generation central to market access. BRICS countries bring scale, biodiversity, traditional medical knowledge, and large aging or rapidly aging populations, with China and India especially influential through institutionalized traditional medicine systems and Brazil through botanical biodiversity and integrative health practices. G7 countries are characterized by high healthcare spending, advanced research capacity, aging demographics, and strong consumer demand for preventive wellness, but they also impose stricter expectations for evidence, labeling, professional accountability, and pharmacovigilance. NATO member countries overlap significantly with mature North American and European healthcare systems, where integrative medicine is increasingly discussed in relation to resilience, mental health, pain management, rehabilitation, and healthy aging, while regulatory coherence and safety standards remain decisive for responsible adoption.

Key Country Insights for Complementary and Alternative Medicine in Anti-Aging and Longevity

China is globally influential through traditional Chinese medicine, acupuncture, herbal formulations, qigong, and government-supported integration of traditional and conventional medical systems, with longevity narratives deeply connected to preventive balance and chronic disease management. The United States has a large and diverse complementary health ecosystem encompassing supplements, functional medicine, chiropractic care, acupuncture, mindfulness, yoga, and integrative clinics, with longevity demand strongly tied to preventive wellness, biomarker tracking, and healthy aging lifestyles. Japan’s aging society and Kampo tradition create a distinctive environment for healthy aging, functional foods, movement practices, and clinical attention to frailty, cognition, and quality of life. India is central to Ayurveda, yoga, meditation, naturopathy, and herbal wellness, with strong relevance for preventive aging, metabolic health, stress reduction, and wellness tourism. Germany has a long-standing tradition of phytotherapy, naturopathy, spa medicine, homeopathy, and integrative approaches, supported by strong consumer familiarity with herbal medicinal products. The United Kingdom has active consumer use of supplements, mindfulness, acupuncture, osteopathy, and nutritional therapies, with emphasis on safety, professional standards, and evidence-based communication. Australia combines strong supplement use, naturopathy, acupuncture, mindfulness, and preventive wellness with regulatory attention to therapeutic goods and practitioner standards. France combines high awareness of herbal products, aromatherapy, nutrition, and wellness practices with a regulatory environment attentive to claims and safety. South Korea is shaped by Korean medicine, ginseng-based products, beauty-from-within trends, digital health adoption, and high consumer interest in healthy aging, cognitive vitality, and skin longevity. Italy and Spain show strong Mediterranean lifestyle foundations, herbal traditions, thermal wellness, nutrition-led prevention, and growing demand for healthy aging services. Canada combines high consumer interest in natural health products with a regulated natural product framework and growing use of integrative approaches for wellness, pain, stress, and aging-related quality of life. Russia has traditions in herbal medicine, balneology, rehabilitation, and preventive wellness, with aging-related interest linked to mobility, immunity, and vitality. Brazil benefits from extensive biodiversity, traditional plant knowledge, and public recognition of integrative and complementary practices, positioning botanical and preventive wellness approaches within a broader healthy aging agenda. Mexico shows strong reliance on traditional remedies, herbal products, and cross-border wellness services, while chronic disease prevention is becoming more important to longevity-oriented consumer behavior.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-based positioning, quality assurance, and responsible personalization. Product developers need robust ingredient authentication, contaminant testing, stability data, transparent labeling, and post-market safety monitoring, especially for botanicals and nutraceuticals used by older adults or people taking medications. Service providers should integrate qualified practitioners, informed consent, clear referral pathways, and outcome tracking to support safe coordination with conventional healthcare. Digital and AI-enabled wellness platforms should implement privacy-by-design, algorithmic transparency, clinical governance, and human oversight while avoiding unsupported longevity claims. Brands should focus education on healthspan-supporting behaviors, including nutrition quality, movement, sleep, stress management, and social wellbeing, while presenting complementary therapies as supportive rather than curative where evidence is limited. Strategic partnerships with academic institutions, healthcare professionals, standards bodies, and traditional knowledge communities can improve credibility, ethical sourcing, and culturally respectful innovation.

Research Methodology

A rigorous research methodology for this sector should combine secondary research, expert validation, regulatory analysis, and evidence grading. Reliable sources include peer-reviewed journals, public health agencies, medicines and food safety regulators, clinical trial registries, standards organizations, demographic databases, and official guidance on dietary supplements, herbal medicines, traditional medicine, and healthy aging. Qualitative inputs from clinicians, traditional medicine practitioners, nutrition experts, regulatory specialists, product quality professionals, and consumer health stakeholders help contextualize adoption patterns and safety concerns. Evidence should be assessed by study design, reproducibility, population relevance, dosage clarity, adverse event reporting, and interaction risk, with special attention to older adults and people with chronic conditions. Claims analysis should distinguish general wellness support from disease treatment claims, and regional comparisons should account for differences in regulation, cultural acceptance, professional licensing, healthcare integration, and consumer protection frameworks.

Conclusion

Complementary and alternative medicine for anti-aging and longevity is entering a more disciplined phase defined by consumer demand for healthy aging, stronger regulatory expectations, digital personalization, and growing emphasis on measurable outcomes. The most resilient opportunities are likely to emerge where traditional knowledge, modern evidence, product quality, ethical sourcing, and practitioner accountability are aligned. Regional diversity remains central: Asia-Pacific anchors many traditional systems, North America drives consumer and digital wellness adoption, Europe emphasizes regulatory structure, Latin America and Africa contribute botanical and community-based traditions, and the Middle East is investing in preventive wellness models. Industry participants that communicate transparently, validate safety, respect cultural origins, and integrate responsibly with conventional healthcare will be best positioned to build trust in the evolving longevity and healthspan ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Complementary & Alternative Medicine For Anti Aging & Longevity Market, by Product Type
7.1. Introduction
7.2. Botanical Extract
7.2.1. Aloe Vera
7.2.2. Gotu Kola
7.3. Dietary Supplement
7.3.1. Amino Acids
7.3.2. Minerals
7.3.3. Probiotics
7.3.4. Vitamins
7.4. Herbal Medicine
7.4.1. Ginseng
7.4.2. Green Tea
7.4.3. Resveratrol
7.4.4. Turmeric
8. Complementary & Alternative Medicine For Anti Aging & Longevity Market, by Product Form
8.1. Introduction
8.2. Tablets & Capsules
8.3. Powders
8.4. Liquids & Tonics
8.5. Gummies & Chewables
8.6. Functional Foods
9. Complementary & Alternative Medicine For Anti Aging & Longevity Market, by End User
9.1. Introduction
9.2. Fitness Center
9.3. Healthcare Provider
9.4. Individual Consumer
9.5. Wellness Center
10. Complementary & Alternative Medicine For Anti Aging & Longevity Market, by Distribution Channel
10.1. Introduction
10.2. Offline Sales
10.3. Online Retail
11. Complementary & Alternative Medicine For Anti Aging & Longevity Market, by Age Group
11.1. Introduction
11.2. 18 To 35 Years
11.3. 36 To 50 Years
11.4. 51 Years And Above
12. Complementary & Alternative Medicine For Anti Aging & Longevity Market, by Gender
12.1. Introduction
12.2. Female
12.3. Male
13. Complementary & Alternative Medicine For Anti Aging & Longevity Market, by Region
13.1. Asia-Pacific
13.2. Europe
13.3. North America
13.4. Latin America
13.5. Africa
13.6. Middle East
14. Complementary & Alternative Medicine For Anti Aging & Longevity Market, by Group
14.1. NATO
14.2. G7
14.3. BRICS
14.4. European Union
14.5. ASEAN
14.6. GCC
15. Complementary & Alternative Medicine For Anti Aging & Longevity Market, by Country
15.1. China
15.2. United States
15.3. Japan
15.4. India
15.5. Germany
15.6. United Kingdom
15.7. Australia
15.8. France
15.9. South Korea
15.10. Italy
15.11. Canada
15.12. Russia
15.13. Brazil
15.14. Mexico
15.15. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Amorepacific Corporation
17.2. Amway Corp.
17.3. Aviv Scientific Ltd
17.4. Bionorica SE
17.5. Columbia Nutritional, LLC
17.6. Dabur India Limited
17.7. First Natural Brands Ltd
17.8. Glanbia Plc
17.9. GNC Holdings, LLC
17.10. H&H International Holdings Ltd
17.11. Herbalife Nutrition Ltd.
17.12. Herbivore Botanicals, LLC
17.13. Jamieson Wellness Inc.
17.14. Kama Ayurveda Private Limited
17.15. LKK Health Products Group Limited
17.16. Maya Reiki School
17.17. Miskawaan Health Group
17.18. Nature’s Sunshine Products, Inc.
17.19. Pascoe pharmazeutische Präparate GmbH
17.20. Patanjali Ayurved Limited
17.21. Pharmavite LLC
17.22. SEVA Wellbeing Meditation LLC
17.23. Sheng Chang Pharmaceutical Co., Ltd.
17.24. The Bountiful Company, LLC
17.25. USANA Health Sciences, Inc.
17.26. VIVAMAYR Maria Wörth Betriebs GmbH
List of Figures
FIGURE 1. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2025 VS 2032 (%)
FIGURE 9. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 11. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 15. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BOTANICAL EXTRACT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BOTANICAL EXTRACT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BOTANICAL EXTRACT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ALOE VERA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ALOE VERA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ALOE VERA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GOTU KOLA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GOTU KOLA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GOTU KOLA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DIETARY SUPPLEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DIETARY SUPPLEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DIETARY SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL AMINO ACIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL AMINO ACIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL AMINO ACIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MINERALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MINERALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MINERALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PROBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PROBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL VITAMINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL VITAMINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL VITAMINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HERBAL MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GINSENG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GINSENG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GINSENG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL GREEN TEA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL GREEN TEA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GREEN TEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL RESVERATROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL RESVERATROL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL RESVERATROL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL TURMERIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL TURMERIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL TURMERIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL TABLETS & CAPSULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL TABLETS & CAPSULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL TABLETS & CAPSULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL POWDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL POWDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL POWDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL LIQUIDS & TONICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL LIQUIDS & TONICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL LIQUIDS & TONICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL GUMMIES & CHEWABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL GUMMIES & CHEWABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GUMMIES & CHEWABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL FUNCTIONAL FOODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL FUNCTIONAL FOODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL FUNCTIONAL FOODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL FITNESS CENTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL FITNESS CENTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL FITNESS CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL HEALTHCARE PROVIDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL HEALTHCARE PROVIDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL HEALTHCARE PROVIDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL INDIVIDUAL CONSUMER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL INDIVIDUAL CONSUMER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL INDIVIDUAL CONSUMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL WELLNESS CENTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL WELLNESS CENTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL WELLNESS CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL OFFLINE SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL OFFLINE SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL OFFLINE SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ONLINE RETAIL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ONLINE RETAIL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ONLINE RETAIL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL 18 TO 35 YEARS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL 18 TO 35 YEARS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL 18 TO 35 YEARS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL 36 TO 50 YEARS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL 36 TO 50 YEARS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL 36 TO 50 YEARS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL 51 YEARS AND ABOVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL 51 YEARS AND ABOVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL 51 YEARS AND ABOVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL FEMALE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL FEMALE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL FEMALE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL MALE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL MALE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL MALE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 107. EUROPE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. EUROPE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. EUROPE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 110. EUROPE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 111. EUROPE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 112. EUROPE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 113. EUROPE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. EUROPE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. EUROPE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 116. EUROPE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 137. AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 139. AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 140. AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 141. AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 142. AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 143. AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 145. AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 146. AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. NATO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. NATO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 160. NATO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 161. NATO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 162. NATO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 163. NATO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 164. NATO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. NATO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 166. NATO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 167. NATO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 168. G7 COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 169. G7 COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 170. G7 COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 171. G7 COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 172. G7 COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 173. G7 COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 174. G7 COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. G7 COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 176. G7 COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 177. G7 COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 178. BRICS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. BRICS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 180. BRICS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 181. BRICS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 182. BRICS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 183. BRICS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 184. BRICS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. BRICS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 186. BRICS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 187. BRICS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 198. ASEAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 199. ASEAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. ASEAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 201. ASEAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 202. ASEAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 203. ASEAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 204. ASEAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. ASEAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 206. ASEAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 207. ASEAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 208. GCC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 209. GCC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 210. GCC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 211. GCC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 212. GCC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 213. GCC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 214. GCC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. GCC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 216. GCC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 217. GCC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 218. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. CHINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 220. CHINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 221. CHINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 222. CHINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 223. CHINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 224. CHINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 225. CHINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. CHINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 227. CHINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 228. CHINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 239. JAPAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 240. JAPAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 241. JAPAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 242. JAPAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 243. JAPAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 244. JAPAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 245. JAPAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 246. JAPAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 247. JAPAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 248. JAPAN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 249. INDIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 250. INDIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 251. INDIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 252. INDIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 253. INDIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 254. INDIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 255. INDIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. INDIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 257. INDIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 258. INDIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 259. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 260. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 261. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 262. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 263. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 264. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 265. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 266. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 267. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 268. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
TABLE 269. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 270. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 271. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2032 (USD MILLION)
TABLE 272. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2032 (USD MILLION)
TABLE 273. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2032 (USD MILLION)
TABLE 274. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 275. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 276. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-20

Companies Mentioned

  • Amorepacific Corporation
  • Amway Corp.
  • Aviv Scientific Ltd
  • Bionorica SE
  • Columbia Nutritional, LLC
  • Dabur India Limited
  • First Natural Brands Ltd
  • Glanbia Plc
  • GNC Holdings, LLC
  • H&H International Holdings Ltd
  • Herbalife Nutrition Ltd.
  • Herbivore Botanicals, LLC
  • Jamieson Wellness Inc.
  • Kama Ayurveda Private Limited
  • LKK Health Products Group Limited
  • Maya Reiki School
  • Miskawaan Health Group
  • Nature’s Sunshine Products, Inc.
  • Pascoe pharmazeutische Präparate GmbH
  • Patanjali Ayurved Limited
  • Pharmavite LLC
  • SEVA Wellbeing Meditation LLC
  • Sheng Chang Pharmaceutical Co., Ltd.
  • The Bountiful Company, LLC
  • USANA Health Sciences, Inc.
  • VIVAMAYR Maria Wörth Betriebs GmbH

Table Information